Recombinant Lipidated PsaA Protein, Methods of Preparation and Use

Details for Australian Patent Application No. 2003204215 (hide)

Owner Center for Disease Control and Prevention Aventis Pasteur

Inventors Huebner, Robert C.; De, Barun K.; Carlone, George M; Sampson, Jacquelyn S.; Ades, Edwin W

Agent Spruson & Ferguson

Pub. Number AU-B-2003204215

Parent 23131

Filing date 15 May 2003

Wipo publication date 19 June 2003

Acceptance publication date 11 January 2007

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

A61K 39/02 (2006.01) Medicinal preparations containing antigens or antibodies - Bacterial antigens

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

Event Publications

29 May 2003 Complete Application Filed

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2003204215

11 January 2007 Application Accepted

  Published as AU-B-2003204215

10 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003204216-Transmitter for Multi-carrier Transmission and Multi-carrier Transmitting Method

2003204214-System and Method for On-line Analysis and Reporting of Financial Operation Data from Community Pharmacies